Autoimmune diseases in pregnancy.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000503:physiopathology; D001327:Autoimmune Diseases; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D008431:Maternal-Fetal Exchange; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000503:physiopathology; D010276:Parasympatholytics / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D011696:Purpura, Thrombocytopenic / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D012595:Scleroderma, Systemic / Q000150:complications
D000305:Adrenal Cortex Hormones; D010276:Parasympatholytics